Nikolova, Simona
Chong, Catherine
Li, Jing
Wu, Teresa
Dumkrieger, Gina
Ross, Katherine
Starling, Amaal
Schwedt, Todd J.
Funding for this research was provided by:
National Institutes of Health (1R61NS113315_01)
U.S. Department of Defense (W81XWH-19-1-0534)
Article History
Received: 25 March 2024
Accepted: 21 May 2024
First Online: 28 May 2024
Declarations
:
: This study was approved by the Mayo Clinic and Phoenix VA Institutional Review Boards.
: All participants completed an informed consent process and signed informed consent forms.
: Within the prior 24 months, TJS has consulted for AbbVie, Amgen, Collegium, Eli Lilly, Linpharma, Lundbeck, Satsuma, Scilex, Theranica. He has received royalties from Up to Date and has held stock options in Aural Analytics and Nocira. He has received research grant support from American Heart Association, Amgen, Henry Jackson Foundation, National Institutes of Health, Patient Centered Outcomes Research Institute, Pfizer, Spark Neuro, United States Department of Defense. He serves on the editorial boards of Cephalalgia, Cephalalgia Reports, and the Journal of Headache and Pain. J.L and C.C have received NIH grants for support for research or education. C.C and G.D have received Amgen grant support for research. T.W serves as editor in chief of the Journal of Alzheimer’s disease. A.S has received consulting fees from AbbVie, Allergan, Axsome Therapeutics, eNeura, Everyday Health, Lundbeck, Med-IQ, Medscape, Miller Medical, Satsuma, and WebMD. S.N and K.R have nothing to disclose.